-
cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_Work_Group_February_2022_slides.pdf
January 01, 2022 - Provider and staff are
part of my community
- ACTIVATE Co-designers
Early Co-Design Lessons:
Help Me Choose … Approaches
Early Co-Design Lessons: Keep My Provider Relationship
Early Co-Design Lessons: �Help Me Choose
-
cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Summary.pdf
January 01, 2022 - March 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
March 17, 2022
3:00 – 4:00 pm ET
Attendees: 37 people, including 4 phone dial-ins
Organization Attendees
AHRQ Sponsors Mario Teran; Roland Gamache; Steve Bernstein (3)
WG Members Andrey…
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - Future implementers may choose to represent ASCVD as an
exclusion based on their needs.
5. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein
(LDL) value … Future implementers may choose to represent ASCVD as an exclusion
based on their needs.
23 … Implementers
may choose to add this capability in the future. … Future implementers may choose to evaluate and track a “baseline” low-density
lipoprotein (LDL) value
-
cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
January 01, 2024 - Those interested in learning more may choose to sign up for one of AHRQ’s newsletters at
https://www.ahrq.gov
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - Future implementers may choose to represent
ASCVD as an exclusion based on their needs.
5. … Future implementers may choose to evaluate and track a “baseline” low-density
lipoprotein (LDL) value … Future
implementers may choose to represent ASCVD as an exclusion based on their needs. … Implementers may choose to add
this capability in the future. … Future
implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value
-
cds.ahrq.gov/sites/default/files/workgroups/1261/CDS_Connect_WG_%20March2021_%20Summary.pdf
March 18, 2021 - the patient and caregiver community might be more
technically proficient than those who currently choose
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
February 01, 2018 - Future implementers may choose to represent
ASCVD as an exclusion based on their needs.
5. … Future implementers may choose to evaluate and track a “baseline” low-density
lipoprotein (LDL) value … Future
implementers may choose to represent ASCVD as an exclusion based on their needs. … Implementers may choose to add
this capability in the future. … Future
implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value
-
cds.ahrq.gov/sites/default/files/workgroups/236/may-2017-cholesterol-wg-notes.docx
January 01, 2017 - recommendation with a verb:
· Look at the GRADE system (e.g., SHOULD means that 90% of the patients would choose
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/NIOSH_Occupational%20Factors%20Impacting%20Diabetes_Decision%20Log_condensed.pdf
February 01, 2018 - Future
implementers may choose to adjust the time frame based on their
preference or organization’s
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
January 01, 2021 - select a value from the dropdown
list (e.g., colleague, conference/workshop,
university class, etc) or choose … These fields allow authors to choose
from example values provided by the FHIR
specification or to … For example,
an author can choose a code-based
property and indicate a set of codes it
should match … As another example,
an author could choose a quantity-based
property and indicate a range it should … Report
21
5.5 Additional Resources
and Modifiers
The CDS Authoring Tool allows authors to
choose
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Clinicians may choose to offer a low- to moderate-dose statin to certain adults without a history of … Grade C Recommendation Statement
Clinicians may choose to offer a low- to moderate-dose statin to certain … intensity statin based on outcome of shared decision between patient and provider)
Grade C
"may choose
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
January 01, 2024 - Organizations that
elect to implement this code will likely choose to expand upon the CDS intervention … Future implementers may choose to utilize other definitions (e.g., some
definitions list different waist … Alternatively, they may choose to map
qualifying data in their system to the CQL code and value sets … Future implementers may choose to
implement other definitions (e.g., some definitions list different … Alternatively, they may choose to map qualifying data in their system to the CQL code as
is.
-
cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
January 01, 2017 - Clinicians and quality leaders (e.g., how to choose and understand the best algorithm or modify the algorithm
-
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
November 11, 2019 - Implementation Guide
Warfarin - NSAIDs
Prepared by:
Eric Chou
Under funding from AHRQ grants R21 HS023826 and R01 HS025984
MDIA publication No. 001
November 11, 2019
Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represen…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - Vendors and integrators may also choose to use the CQL Testing
https://cds.ahrq.gov/cdsconnect/repository … Future implementers may choose to support
patients younger than 18. … clinician via a link in the EHR during the MITRE pilot of this
work, the clinician or health system may choose … Future implementers of this artifact may choose to include alerts reinforcing specific CDC or other … Future implementers may choose to remove this criterion or expand the
inclusion logic.
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final.pdf
January 01, 2020 - Vendors and integrators may also
choose to use the CQL Testing Framework to test any site- or product-specific … Persons who place a higher value on the potential
12
benefits than the potential harms may choose … Persons who place a higher value on the potential benefits than the potential harms may choose to
initiate
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation%20Guide_Healthful%20Diet%20and%20Physical%20Activity_Final.pdf
September 01, 2019 - Organizations that
elect to implement this code will likely choose to expand upon the CDS intervention … Future implementers may choose to
utilize other definitions (e.g., some definitions list different waist … Alternatively, they may choose to map
qualifying data in their system to the CQL code and value sets … Future implementers may choose to implement other
definitions (e.g., some definitions list different … Alternatively, they may choose to map qualifying
data in their system to the CQL code as is.
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
January 01, 2020 - Vendors and integrators may also
choose to use the CQL Testing Framework to test any site- or product-specific … Organizations that
elect to implement this code will likely choose to expand upon the CDS intervention … patients is
moderate to substantial.6 The recommendation summary also states that “clinicians may choose … cardiovascular event of 10 percent or greater.”2 The
USPSTF recommendation summary also states, “clinicians may choose … 7.5 percent – 10 percent for the Grade C recommendaiton.2 Future implementers
can elect whether they choose
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - Persons who place a higher value on the potential benefits than the potential harms may choose to initiate … Persons who place a higher value on the potential benefits than the potential harms may choose to initiate
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final_2.pdf
April 01, 2021 - Vendors and integrators may also
choose to use the CQL Testing Framework to test any site- or product-specific … Persons who place a higher value on the potential
benefits than the potential harms may choose to initiate … Persons who place a higher value on the potential benefits than the potential harms may choose to
initiate